Yahoo Search Busca da Web

Resultado da Busca

  1. Mary Frances Earley Klotman (born 1954) is an American physician-scientist and academic administrator. She was elected as a member of the National Academy of Medicine in 2014 and became the editor of the Annual Review of Medicine in 2020. She has been the dean of the Duke University School of Medicine since 2017.

    • 2
    • Mary Frances Earley, 1954 (age 68–69), Long Island, New York
  2. Chief Academic Officer, Duke Health. A nationally recognized leader in academic medicine, Mary E. Klotman, MD, is executive vice president for health affairs at Duke University, dean of the Duke University School of Medicine, and chief academic officer for Duke Health.

  3. Executive Vice President for Health Affairs, Duke University and Dean of the School of Medicine. Dr. Klotman became Executive Vice President for Health Affairs in July 2023.

  4. corporate.dukehealth.org › people › mary-klotman-mdMary Klotman, MD | Duke Health

    A nationally recognized leader in academic medicine, Mary E. Klotman, MD, is executive vice president for health affairs at Duke University, dean of the Duke University School of Medicine, and chief academic officer for Duke Health.

  5. Mary E Klotman. R.J. Reynolds Distinguished Professor of Medicine. Professor of Medicine. Dean, School of Medicine. Executive Vice President of Health Affairs. Professor in Molecular Genetics and Microbiology. Professor of Pathology. Member of the Duke Human Vaccine Institute. Education.

  6. Professor of Medicine. Dean, School of Medicine. Executive Vice President of Health Affairs. Professor in Molecular Genetics and Microbiology. Professor of Pathology. Member of the Duke Human Vaccine Institute. Davison Building Room 125, Box 2927, Durham, NC 27710. DUMC 2927, Davison Building Room 125, Durham, NC 27710. (919) 684-2455.

  7. medx.duke.edu › community › mary-klotmanKlotman | MEDx

    Mary E Klotman. R.J. Reynolds Distinguished Professor of Medicine. Dr. Klotman became Dean of the Duke School of Medicine in June 2017. An accomplished clinician and scientist, Klotman’s research interests are focused on the molecular pathogenesis of Human Immunodeficiency Virus 1 (HIV-1) infection.